Autori: Zafrir Barak
| Naslov | Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14,964 patients in the ESC heart failure long-term registry (Meeting Abstract) |
| Autori | Zafrir Barak Lund Lars H Laroche Cecile Ruschitzka Frank Crespo-Leiro Maria G Coats Andrew JS Anker Stefan D Filippatos Gerasimos Seferovic Petar M Maggioni Aldo P Amir Offer |
| Info | EUROPEAN HEART JOURNAL, (2018), vol. 39 br. , Suppl. 1, str. 678-679 |
| Projekat | EURObservational Research Programme (EORP) |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry (Article) |
| Autori | Zafrir Barak Lund Lars H Laroche Cecile Ruschitzka Frank Crespo-Leiro Maria G Coats Andrew JS Anker Stefan D Filippatos Gerasimos Seferovic Petar M Maggioni Aldo P De Mora Martin Manuel Polonski Lech Silva-Cardoso Jose Amir Offer |
| Info | EUROPEAN HEART JOURNAL, (2018), vol. 39 br. 48, str. 4277-4284 |
| Projekat | Abbott Vascular Int.; Amgen Cardiovascular; AstraZeneca; Bayer AG; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Pfizer Alliance; Daiichi Sankyo Europe GmbH; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Edwards; Gedeon Rich |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
